Connect Biopharma Holdings Limited
CNTB
$2.65
-$0.01-0.38%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -33.34% | -25.57% | 11.74% | 9.61% | -186.72% |
| Total Depreciation and Amortization | 4.68% | -1.16% | 88.04% | -47.73% | 8.64% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 12.67% | -8.80% | -71.23% | 24.54% | 2.53% |
| Change in Net Operating Assets | -115.21% | 10.39% | -148.90% | 151.39% | 90.54% |
| Cash from Operations | -38.24% | -26.43% | -27.37% | 39.89% | -69.03% |
| Capital Expenditure | 88.78% | -274.07% | 48.41% | -6.80% | 49.31% |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 164.73% | 126.42% | -166.80% | -- | -100.00% |
| Cash from Investing | 179.70% | 124.85% | -162.47% | -5,249.66% | -104.58% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 33.54% | 7,950.00% | -96.80% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 33.54% | 7,950.00% | -98.53% | -- | -100.00% |
| Foreign Exchange rate Adjustments | -74.11% | 198.67% | 129.70% | -149.80% | 397.06% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 60.62% | 76.81% | -93.20% | -24.92% | -196.74% |